Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

amifampridine

An organic compound derived from pyridine with potassium channel inhibition activity. Amifampridine inhibits potassium channel efflux, increasing the duration of the action potential, which results in an increase in the duration of calcium channel opening and enhanced acetylcholine (ACh) release. Increased ACh availability at the motor end plate allows muscles to contract.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	3,4-pyridinediamine 4,5-diaminopyridine
Foreign brand name:	Firdapse
Abbreviation:	3,4-DAP
Code name:	SC10
Chemical structure:	3,4-diaminopyridine pyridine, 3,4-diamino-

amifampridine

Search NCI's Drug Dictionary